AZN:NYSE
AstraZeneca PLC (US)
$ 155.82
arrow_downward
-1.59%(-2.51) 1D
$ 155.82
0.00% (0.00)
bedtimeAfter hours
Closed: 10-р сарын 13, 16:00:03 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AZN...
Open
$ 160.76
High
$ 160.83
Low
$ 154.00
Mkt. cap
242.43Т
Avg. vol.
2.91 сая
Volume
3.11 сая
Dividend
2.07%
Quarterly dividend
$ 0.81
Ex-dividend date
2026 оны 8-р сарын 6
P/E ratio
23.29
52-wk high
$ 212.71
52-wk low
$ 80.48
EPS
$ 6.69
Beta
0.30
Shares outstanding
1.55 тэрбум
No. of employees
96 мян
Open
$ 160.76
High
$ 160.83
Low
$ 154.00
Mkt. cap
242.43Т
Avg. vol.
2.91 сая
Volume
3.11 сая
Dividend
2.07%
Quarterly dividend
$ 0.81
Ex-dividend date
2026 оны 8-р сарын 6
P/E ratio
23.29
52-wk high
$ 212.71
52-wk low
$ 80.48
EPS
$ 6.69
Beta
0.30
Shares outstanding
1.55 тэрбум
No. of employees
96 мян
News stories
From web sources and news partners
TipRanks
·
11 цагийн өмнө
AstraZeneca’s Pediatric Nexium Study Moves Toward Data Readout, Supporting Long-Term GI Franchise
Kalkine Media
·
17 цагийн өмнө
Can AstraZeneca (LSE:AZN) Keep Its Growth Story Intact After A Mixed Run Of Trial Readouts?
Traders Union
·
19 цагийн өмнө
AstraZeneca stock consolidates amid mixed clinical trial results and new oncology partnership
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About AstraZeneca PLC (US)
CEOPascal Soriot
Employees96.1 мян
Founded1999 оны 4-р сарын 6
HeadquartersCambridge, Cambridgeshire, Их Британи
SectorPharmaceutical industry
Websiteastrazeneca.com